Travere Therapeutics to Report Second Quarter 2026 Financial Results

Go back to Travere Therapeutics to Report Second Quarter 2026 Financial Results
(NASDAQ: TVTX) Delayed: 62.86 --0 (-0%)
Previous Close $62.86    52 Week High
Open $62.86    52 Week Low
Day High $62.86    P/E N/A 
Day Low $62.86    EPS
Volume 2,410